Skip to content

Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction

Prospective Multicentre Non-interventional Comparative Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01590537
Acronym
Mirabel
Enrollment
2348
Registered
2012-05-03
Start date
2011-09-30
Completion date
2014-10-31
Last updated
2015-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Keywords

non-interventional, Mirena, Contraception, Russian Federation

Brief summary

This is local prospective, non-interventional multi-center comparative study. Primary study objective is evaluation of the user satisfaction with Mirena or Copper IUD up to 1 year after insertion ( patient assessment questionnaire) in daily practice. For each patient, the treating gynecologist documents demographics, medical data, safety parameters and treatment signs and symptoms at an initial visit and one or two follow-up visit(s).

Interventions

intrauterine system containing 52 mg levonorgestrel, with daily release of 20 mcg levonorgestrel

Copper device, inserted intrauterine

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Women 20-40 years old * Parity ≥ 1 child * Requesting long-term contraception * Written informed consent.

Exclusion criteria

* in accordance with the current leaflet

Design outcomes

Primary

MeasureTime frame
User satisfaction of the contraception method with Mirena or Copper IUDup to 12 months

Secondary

MeasureTime frame
Safety evaluation of Mirena or Copper IUD in routine practice Safety parameters include number of AEs, severity,relationship to Mirena or Cooper IUDup to 12 months
Contraceptive reliability of Mirena or Cooper IUD in routine practice ( fixing number of pregnancies)up to 12 months
Continuation/discontinuation rate ( number of cases with contraceptive method continuation and discontinuations)up to 12 months
Relationship between different parameters and women preferences in choosing Mirena or Cooper IUD as their contraceptive method ( demographic parameters, age group, residence, reproductive history and plans, etc.) using patients questionnaireup to 12 months

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026